河南作为关键市场，为公司AI医疗技术进行大规模、深层次实践提供了绝佳场景。 本文为IPO早知道原创 作者｜ 罗宾 微信公众号｜ipozaozhidao 据IPO早知道消息，近日，商汤医疗正式引入河南汇融人工智能产业投资基金近亿元战略投资，凯乘 资本继续担任财务顾问。作为河南省首支专注于人工智能领域的产业主题基金，此次投资方战略注资 不仅是对商汤医疗技术实力与商业模式的认可，更标志着公司"AI+医疗"战略在中原地区的深化布 局，双方将共同推动智慧医疗解决方案的区域化落地与产业协同。 战略协同：前沿技术与区域发展需求的双向奔赴 河南汇融人工智能产业投资基金，是河南省在人工智能领域的关键资本平台，其基金重点投向AI+垂 类应用、算力硬件、具身智能及AI Infra四大核心赛道。 河南作为人口大省，其庞大的医疗服务需求、复杂的医疗资源分布现状以及迫切的体系化转型需要， 共同构成了AI医疗技术进 行大规模、深层次实践 的绝佳场景。 对商汤医疗而言，引入此次战略投资，实现了前沿技术能力与区域发展战略的精准匹配，同时也是推 动公司 "AI+医疗"全栈解决方案在关键市场进行 规模化验证与体系化落地 的战略举措。 未来，商汤医 ...

Core Viewpoint - SenseTime Medical has completed a new round of strategic financing amounting to several hundred million yuan, with notable investors including Lenovo Ventures and others, aimed at enhancing its medical AI and large model capabilities, expanding its product matrix, and deepening market presence [2][12]. Company and Technology Background - SenseTime Medical is a core business unit under SenseTime Technology, focusing on medical AI and smart hospital solutions, leveraging the company's foundational technologies in computer vision, deep learning, and large models [3]. - The core platform, SenseCare, integrates image recognition, multimodal data fusion, AI reasoning, and large language model technologies to provide automated and structured analysis and decision support across various medical disciplines [3]. Product System and Commercialization Progress - SenseTime Medical has developed a comprehensive product system centered around the SenseCare smart hospital solution, covering diagnosis, research, patient services, and cloud management, driven by multimodal large models and a medical language model [4][11]. - The product offerings include: - SenseCare Medical: AI-assisted diagnosis and reporting for core clinical departments [6]. - SenseCare PatientAssist: AI navigation and patient management to enhance service efficiency [7]. - SenseCare Research: Full-process capabilities for research institutions and hospitals [7]. - SenseCare Cloud: A secure and efficient cloud infrastructure for medical data interconnectivity [8]. Financing Significance and Future Outlook - The recent strategic financing will strengthen SenseTime Medical's core advantages in medical AI model development and algorithm iteration, supporting higher-level multimodal training and clinical validation [12]. - The financing is expected to accelerate the company's commercialization process, with plans to expand market coverage domestically and internationally over the next two years [13]. - SenseTime Medical aims to enhance its smart medical ecosystem through a comprehensive system of "AI + Cloud + Research + Decision," positioning itself as a key partner in the digital transformation of healthcare institutions [13]. Conclusion - SenseTime Medical is transitioning from an AI technology provider to a builder of medical ecosystems, with new capital injection and a complete product system enhancing its influence in the medical AI field [14]. - As the regulatory framework for medical AI evolves, companies with capabilities in model development, multimodal data processing, cloud infrastructure, and integrated clinical services are likely to become industry leaders [14].